GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Regenerex Pharma Inc (OTCPK:PEPT) » Definitions » Cyclically Adjusted PB Ratio

PEPT (Regenerex Pharma) Cyclically Adjusted PB Ratio : (As of Sep. 21, 2024)


View and export this data going back to . Start your Free Trial

What is Regenerex Pharma Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Regenerex Pharma Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Regenerex Pharma's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenerex Pharma Cyclically Adjusted PB Ratio Chart

Regenerex Pharma Annual Data
Trend Nov10 Nov11 Nov12 Nov13 Nov14 Mar17 Mar18 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Regenerex Pharma Quarterly Data
Nov14 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Regenerex Pharma's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Regenerex Pharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regenerex Pharma's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Regenerex Pharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Regenerex Pharma's Cyclically Adjusted PB Ratio falls into.



Regenerex Pharma Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Regenerex Pharma's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Regenerex Pharma's adjusted Book Value per Share data for the three months ended in Jun. 2024 was:

Adj_Book=Book Value per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.016/132.5538*132.5538
=-0.016

Current CPI (Jun. 2024) = 132.5538.

Regenerex Pharma Quarterly Data

Book Value per Share CPI Adj_Book
200911 0.000 91.272 0.000
201002 0.000 91.445 0.000
201005 0.000 92.052 0.000
201008 0.000 92.108 0.000
201011 0.000 92.315 0.000
201102 0.000 93.373 0.000
201105 0.000 95.337 0.000
201108 0.002 95.582 0.003
201111 -0.001 95.449 -0.001
201202 -0.002 96.053 -0.003
201205 -0.002 96.961 -0.003
201208 -0.002 97.199 -0.003
201211 -0.005 97.133 -0.007
201302 -0.007 97.953 -0.009
201305 -0.008 98.282 -0.011
201308 -0.010 98.675 -0.013
201311 -0.011 98.334 -0.015
201402 -0.012 99.057 -0.016
201405 -0.005 100.373 -0.007
201408 -0.005 100.352 -0.007
201411 -0.005 99.635 -0.007
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 -0.002 102.862 -0.003
201706 -0.002 103.349 -0.003
201709 -0.002 104.136 -0.003
201712 -0.003 104.011 -0.004
201803 -0.003 105.290 -0.004
201806 -0.003 106.317 -0.004
201809 -0.003 106.507 -0.004
202203 -0.004 121.301 -0.004
202206 -0.008 125.017 -0.008
202209 -0.004 125.227 -0.004
202212 -0.005 125.222 -0.005
202303 -0.004 127.348 -0.004
202306 -0.004 128.729 -0.004
202309 -0.013 129.860 -0.013
202312 -0.014 129.419 -0.014
202403 -0.015 131.776 -0.015
202406 -0.016 132.554 -0.016

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Regenerex Pharma  (OTCPK:PEPT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Regenerex Pharma Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Regenerex Pharma's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Regenerex Pharma Business Description

Traded in Other Exchanges
N/A
Address
5348 Vegas Drive, Suite 177, Las Vegas, NV, USA, 89108
Regenerex Pharma Inc develops and markets Woundcare Healing products. The current product technology provides the Company with a number of complete wound care protocols to treat all wounds, such as diabetic ulcers, pressure ulcers, burns, and surgical wounds. Its product Xcellderma OTC a Liquid Bandage Skin Protectant Xcellderma products are sterile wound dressings for treating diabetic foot ulcers, pressure ulcers, and other chronic wounds; Accelerex Sterile Wound Cream is for the treatment of a wide variety of chronic and acute wounds; and Accelerex Impregnated Sterile Wound Dressing use as a wound dressing to manage pressure ulcers (stages I-IV), stasis ulcers, diabetic skin ulcers, skin irritations, cuts, and abrasions.

Regenerex Pharma Headlines

No Headlines